First Time Loading...

Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 175 NOK -0.57%
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one MEDI stock under the Base Case scenario is 268.65 NOK. Compared to the current market price of 175 NOK, Medistim ASA is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDI Relative Value
Base Case
268.65 NOK
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6
P/S
P/S
Price to Sales
6
vs History
96
vs Industry
22
Median 3Y
9.7
Median 5Y
9.5
Industry
2.4
Forward
5.7
More Details
31.3
P/E
P/E
Price to Earnings
31.3
vs History
93
vs Industry
19
Median 3Y
45.1
Median 5Y
45.1
Industry
23.9
Forward
28.1
More Details
23.8
P/OCF
P/OCF
Price to OCF
23.8
vs History
98
vs Industry
17
Median 3Y
37.4
Median 5Y
38.3
Industry
15.6
More Details
25.5
P/FCFE
P/FCFE
Price to FCFE
25.5
vs History
98
vs Industry
21
Median 3Y
43.8
Median 5Y
43.4
Industry
22.5
More Details
7.5
P/B
P/B
Price to Book Value
7.5
vs History
98
vs Industry
9
Median 3Y
13.5
Median 5Y
13.2
Industry
2.3
More Details
5.7
EV/S
EV/S
Enterprise Value to Sales
5.7
vs History
96
vs Industry
21
Median 3Y
9.6
Median 5Y
9.3
Industry
2.5
Forward
5.4
More Details
7.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.3
vs History
96
vs Industry
31
Median 3Y
12.1
Median 5Y
11.9
Industry
5.3
More Details
23.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
23.4
vs History
87
vs Industry
14
Median 3Y
34.5
Median 5Y
33.3
Industry
12.9
Forward
17.2
More Details
23.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.4
vs History
95
vs Industry
20
Median 3Y
34.8
Median 5Y
34.8
Industry
17.8
Forward
19.3
More Details
22.6
EV/OCF
EV/OCF
Enterprise Value to OCF
22.6
vs History
98
vs Industry
19
Median 3Y
36.2
Median 5Y
38
Industry
15.4
More Details
22.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.6
vs History
98
vs Industry
22
Median 3Y
38.9
Median 5Y
39.3
Industry
19.6
More Details
8.5
EV/IC
EV/IC
Enterprise Value to IC
8.5
vs History
96
vs Industry
10
Median 3Y
15.2
Median 5Y
13.8
Industry
2
More Details

Multiples Across Competitors

MEDI Competitors Multiples
Medistim ASA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NO
Medistim ASA
OSE:MEDI
3.2B NOK 6 31.3 23.4 23.4
US
Abbott Laboratories
NYSE:ABT
180.9B USD 4.5 32.1 19 28.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
136.3B USD 18.6 68.6 56.3 70.5
US
Stryker Corp
NYSE:SYK
123.5B USD 5.9 36.8 23.9 29.4
IE
Medtronic PLC
NYSE:MDT
112.1B USD 3.5 26.7 14.1 20
US
Boston Scientific Corp
NYSE:BSX
108B USD 7.3 61.2 30.8 45.5
US
Becton Dickinson and Co
NYSE:BDX
67.9B USD 3.5 55.7 18.6 39.4
DE
Siemens Healthineers AG
XETRA:SHL
59B EUR 2.7 39 18.6 31.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
376.2B CNY 10.5 30.9 28.4 28.4
US
Edwards Lifesciences Corp
NYSE:EW
52B USD 8.5 36.8 26.7 28.9
US
Dexcom Inc
NASDAQ:DXCM
49.9B USD 13.1 78 58.3 76

See Also

Summary
MEDI intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDI stock valuation using valuation multiples.
Wall Street Estimates
MEDI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.